About the Authors

Per Venge

Roles Conceptualization, Investigation, Writing – original draft

per.venge@medsci.uu.se

Affiliation Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Christer Peterson

Roles Investigation, Methodology

Affiliations Department of Medical Sciences, Uppsala University, Uppsala, Sweden, Diagnostics Development, Uppsala, Sweden

Shengyuan Xu

Roles Investigation, Methodology

Affiliations Department of Medical Sciences, Uppsala University, Uppsala, Sweden, Diagnostics Development, Uppsala, Sweden

Anders Larsson

Roles Methodology, Writing – review & editing

Affiliation Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Joakim Johansson

Roles Investigation, Writing – review & editing

Affiliation Department of Surgical and Perioperative Sciences, Anaesthesiology and Intensive Care Medicine (Östersund), Umeå University, Umeå, Sweden

Jonas Tydén

Roles Investigation, Writing – review & editing

Affiliation Department of Surgical and Perioperative Sciences, Anaesthesiology and Intensive Care Medicine (Östersund), Umeå University, Umeå, Sweden

Competing Interests

Per Venge is a board member and shareholder of P&M Venge AB which owns patent rights on the use of HNL in infectious disease. I am the part owner of the company Diagnostics Development a P&M Venge AB company, which holds the patents relating to the results of this report. The identities of the patents are included in the disclosure section. My ownership does not alter the adherence to PLOS ONE policies on sharing data and materials.